PortfoliosLab logoPortfoliosLab logo
LEGN vs. COST
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

LEGN vs. COST - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Legend Biotech Corporation (LEGN) and Costco Wholesale Corporation (COST). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, LEGN achieves a 65.50% return, which is significantly higher than COST's 11.85% return.


LEGN

1D
-0.83%
1M
35.77%
YTD
65.50%
6M
29.66%
1Y
26.56%
3Y*
-17.20%
5Y*
-1.43%
10Y*

COST

1D
0.79%
1M
-5.03%
YTD
11.85%
6M
4.58%
1Y
-8.37%
3Y*
25.00%
5Y*
21.24%
10Y*
22.34%
*Multi-year figures are annualized to reflect compound growth (CAGR)

LEGN vs. COST - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
LEGN
Legend Biotech Corporation
65.50%-33.19%-45.92%20.53%7.10%65.52%-23.89%
COST
Costco Wholesale Corporation
11.85%-5.39%39.62%49.00%-19.05%51.82%24.42%

Correlation

The correlation between LEGN and COST is 0.04, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.04

Correlation (3Y)
Calculated over the trailing 3-year period

0.08

Correlation (5Y)
Calculated over the trailing 5-year period

0.12

Correlation (All Time)
Calculated using the full available price history since Jun 8, 2020

0.11

Fundamentals

EPS

LEGN:

-$1.55

COST:

$26.51

PS Ratio

LEGN:

5.09

COST:

1.09

Total Revenue (TTM)

LEGN:

$1.14B

COST:

$293.59B

Gross Profit (TTM)

LEGN:

$611.63M

COST:

$11.12B

EBITDA (TTM)

LEGN:

-$186.04M

COST:

$12.48B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

LEGN vs. COST — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

LEGN
LEGN Risk / Return Rank: 5454
Overall Rank
LEGN Sharpe Ratio Rank: 5454
Sharpe Ratio Rank
LEGN Sortino Ratio Rank: 6262
Sortino Ratio Rank
LEGN Omega Ratio Rank: 5858
Omega Ratio Rank
LEGN Calmar Ratio Rank: 5050
Calmar Ratio Rank
LEGN Martin Ratio Rank: 4949
Martin Ratio Rank

COST
COST Risk / Return Rank: 2222
Overall Rank
COST Sharpe Ratio Rank: 2121
Sharpe Ratio Rank
COST Sortino Ratio Rank: 1919
Sortino Ratio Rank
COST Omega Ratio Rank: 2020
Omega Ratio Rank
COST Calmar Ratio Rank: 2626
Calmar Ratio Rank
COST Martin Ratio Rank: 2323
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

LEGN vs. COST - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Legend Biotech Corporation (LEGN) and Costco Wholesale Corporation (COST). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


LEGNCOSTDifference
Sharpe ratioReturn per unit of total volatility

+0.83

Sortino ratioReturn per unit of downside risk

+1.84

Omega ratioGain probability vs. loss probability

1.15

0.94

+0.21

Calmar ratioReturn relative to maximum drawdown

0.43

-0.44

+0.87

Martin ratioReturn relative to average drawdown

0.67

-0.88

+1.55

LEGN vs. COST - Sharpe Ratio Comparison

The current LEGN Sharpe Ratio is 0.39, which is higher than the COST Sharpe Ratio of -0.44. The chart below compares the historical Sharpe Ratios of LEGN and COST, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


LEGNCOSTDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.39

-0.44

+0.83

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.03

0.94

-0.97

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

1.02

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.01

0.59

-0.59

Drawdowns

LEGN vs. COST - Drawdown Comparison

The maximum LEGN drawdown since its inception was -78.24%, which is greater than COST's maximum drawdown of -53.39%. Use the drawdown chart below to compare losses from any high point for LEGN and COST.


Loading charts...

Drawdown Indicators


LEGNCOSTDifference

Max Drawdown

Largest peak-to-trough decline

-78.24%

-53.39%

-24.85%

Max Drawdown (1Y)

Largest decline over 1 year

-62.43%

-18.95%

-43.48%

Max Drawdown (3Y)

Largest decline over 3 years

-78.24%

-20.74%

-57.50%

Max Drawdown (5Y)

Largest decline over 5 years

-78.24%

-31.40%

-46.84%

Max Drawdown (10Y)

Largest decline over 10 years

-31.40%

Current Drawdown

Current decline from peak

-52.97%

-12.11%

-40.86%

Average Drawdown

Average peak-to-trough decline

-31.34%

-13.36%

-17.98%

Ulcer Index

Depth and duration of drawdowns from previous peaks

39.47%

9.86%

+29.61%

Volatility

LEGN vs. COST - Volatility Comparison

Legend Biotech Corporation (LEGN) has a higher volatility of 40.69% compared to Costco Wholesale Corporation (COST) at 8.05%. This indicates that LEGN's price experiences larger fluctuations and is considered to be riskier than COST based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


LEGNCOSTDifference

Volatility (1M)

Calculated over the trailing 1-month period

40.69%

8.05%

+32.64%

Volatility (6M)

Calculated over the trailing 6-month period

57.77%

14.83%

+42.94%

Volatility (1Y)

Calculated over the trailing 1-year period

69.00%

19.12%

+49.88%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

56.04%

22.73%

+33.31%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

55.65%

21.95%

+33.70%

Dividends

LEGN vs. COST - Dividend Comparison

LEGN has not paid dividends to shareholders, while COST's dividend yield for the trailing twelve months is around 0.56%.


PositionTTM20252024202320222021202020192018201720162015
COST
Costco Wholesale Corporation
0.56%0.59%0.49%2.87%0.76%0.54%3.38%0.86%1.08%4.81%1.09%4.06%
LEGN
Legend Biotech Corporation
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

LEGN vs. COST - Financials Comparison

This section allows you to compare key financial metrics between Legend Biotech Corporation and Costco Wholesale Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00B40.00B60.00B80.00B20222023202420252026
306.01M
70.53B
(LEGN) Total Revenue
(COST) Total Revenue
Values in USD except per share items

LEGN vs. COST - Profitability Comparison

The chart below illustrates the profitability comparison between Legend Biotech Corporation and Costco Wholesale Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

-100.0%-50.0%0.0%50.0%100.0%20222023202420252026
37.2%
-25.1%
Portfolio components
LEGN - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Legend Biotech Corporation reported a gross profit of 113.94M and revenue of 306.01M. Therefore, the gross margin over that period was 37.2%.

COST - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Costco Wholesale Corporation reported a gross profit of -17.68B and revenue of 70.53B. Therefore, the gross margin over that period was -25.1%.

LEGN - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Legend Biotech Corporation reported an operating income of -47.04M and revenue of 306.01M, resulting in an operating margin of -15.4%.

COST - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Costco Wholesale Corporation reported an operating income of 2.82B and revenue of 70.53B, resulting in an operating margin of 4.0%.

LEGN - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Legend Biotech Corporation reported a net income of -54.46M and revenue of 306.01M, resulting in a net margin of -17.8%.

COST - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Costco Wholesale Corporation reported a net income of 2.19B and revenue of 70.53B, resulting in a net margin of 3.1%.


Frequently Asked Questions


LEGN and COST have a correlation of 0.04, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

LEGN has higher volatility (40.69%) compared to COST (8.05%). In terms of maximum drawdown, LEGN dropped -78.24% vs COST's -53.39%.

LEGN currently has the higher Sharpe Ratio (0.39 vs -0.44), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for LEGN and COST

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer